Salmeterol 50(ug) bid significantly increases through fev(i) in COPD up to 12 months without loss of effect

Robert Stockley, MK Williams, PJ Whitehead

Research output: Contribution to conference (unpublished)Paper

Original languageEnglish
Pages376s
Publication statusPublished - 1 Jan 2003

Cite this